
Danish Biotech Weekly – Week 27
Danish Biotech Weekly with insights to listed Danish biotech companies. We keep you updated on their news flow including updates on clinical trials, acquisitions, insider
Danish Biotech Weekly with insights to listed Danish biotech companies. We keep you updated on their news flow including updates on clinical trials, acquisitions, insider
In May, the current CEO of Ekobot resigned from his position, causing turmoil and a falling share price. The company has now found its new
Mdundo is guiding for strong growth for the 2023/24 financial year and remains on course for its long-term goals in 2025. Will this also put
Danish Biotech Weekly with insights to listed Danish biotech companies. We keep you updated on their news flow including updates on clinical trials, acquisitions, insider
Danish Biotech Weekly with insights to listed Danish biotech companies. We keep you updated on their news flow including updates on clinical trials, acquisitions, insider
Kapital Partner has advised the Dutch company Azerion Group NV [AZRN] – a leading entertainment and media platform – and the company’s primary shareholder, Principion
Kapital Partner har rådgivet Nexcom [NEXCOM] omkring kapitalstruktur og har bistået selskabet i forbindelse med selskabets kapitalrejsning via en privatplacering. Kapital Partner har således endnu